INTRODUCTION local anesthesia refers to loss of sensation in a limited region of the body. Local and regional techniques can be used to provide anaesthesia for many surgical procedures. They can also provide good-quality post-operative analgesia, especially when using continuous epidural infusions. A local anaesthetic may be the method of choice for patients with severe cardiorespiratory disease, as the risks of general anaesthesia and systemic narcotic analgesics are avoided. Local anaesthetic techniques have also proved useful in combination with general anaesthesia. Local anesthetics (LA) are drugs employed to produce a transient and reversible loss of sensation in a circumscribed area of the body by interfering with nerve conduction (both sensory and motor) and without loss of consciousness Useful drugs must be: Water soluble. Serializable by heat. Have a rapid onset of effect. Have a duration of action suitable to the operation performed. Be non-toxic. Leave no local after effects. BASIC PHARMACOLOGY OF LOCAL ANESTHETICS Most local anesthetic agents consist of a lipophilic group (eg, an aromatic ring) connected by an intermediate chain via an ester or amide to an ionizable group (e.g., a tertiary amine) Most local anesthetic agents consist of a lipophilic group (eg, an aromatic ring) connected by an intermediate chain via an ester or amide to an ionizable group (e.g., a tertiary amine). Because ester (e.g. cocaine, procaine, tetracaine and benzocaine) links are more prone to hydrolysis than amide links, esters usually have a shorter duration of action. Local anesthetics are weak bases and are usually made available clinically as salts to increase solubility and stability.
In the body, they exist either as the uncharged
base or as a cation.
The relative proportions of these two forms are
governed by their pKa and the pH of the body fluids according to the Henderson-Hasselbalch equation, which can be expressed as: pKa = pH – log [base]/[conjugate acid] Mode of action: LA prevent the nerve impulses from arising and propagating by interfering with the rate of rise of the depolarization phase of the action potential.
Also the threshold of excitation increases
and the impulse conduction slows , finally the cell does not depolarize sufficiently to fire and therefore propagating action potential fails to occur. LA accomplish this by reducing the passage of Na+ through the voltage gated Na+ channels. Increase in extracellular Ca partially antagonizes the action of LA, this is probably because LA compete with Ca ions for a site in the nerve membrane that controls the passage of Na+ through these channels. The fibers in the nerve trunks are affected according to: 1- Fiber diameter: The small fibers are first affected (autonomic, sensory) and then the larger myelinated motor fibers. Type B(preganglionic autonomic) then type C (dorsal root for pain) and then the small type A delta fiber (pain and temperature) and then type A beta (touch and pressure) and then type A alpha (proprioception, motor). The time of onset of action is shorter for the smaller fibers and the concentration of the drug required is also less. 2- Myelination: Myelinated nerves tend to become blocked before the unmyelinated nerve of the same diameter , for this reason pre- ganglionic B fibers may be blocked before the unmyelinated C fibers involved in pain transmission. For myelinated fibers at least two successive nodes must be blocked by The LA to halt impulse propagation. 3- Firing frequency (conduction velocity): LA effect is more marked on fibers of higher frequencies of depolarization and longer periods of depolarization especially pain fibers. Motor fibers fire at a slower rate and have a shorter action potential duration . 4- Fiber position: The location of the fiber in the peripheral nerve bundle whether sensory or motor is important. Fibers located circumferentially are blocked first because they are the first to be exposed to the drug therefore it is not uncommon that motor nerves are blocked before the sensory in large mixed nerve. Local anaesthetics depress small unmyelinated fibers first and larger myelinated fibers last. The order of loss of function is therefore as follows: • pain; • temperature; • touch; • motor function. BUPIVACAINE Is a long-acting amide local anaesthetic commonly used for epidural and spinal anaesthesia. Although it has a slow onset, peripheral nerve and plexus blockade can have a duration of 5–12 hours. Epidural blockade is much. shorter, at about two hours, but is still longer than for lidocaine. The relatively short duration of epidural block is related to the high vascularity of the epidural space and consequent rapid uptake of anaesthetic into the bloodstream. Bupivacaine is the agent of choice for continuous epidural blockade in obstetrics, as the rise in maternal (and therefore fetal) plasma concentration occurs less rapidly than with lidocaine. The acute central nervous system toxicity of bupivacaine is similar to that of lidocaine, it is thought to be more toxic to the myocardium. LIDOCAINE It has a quick onset and medium duration of action. In addition to injection, lidocaine can be administered topically as a gel or aerosol. It is used in all forms of local anaesthesia. Absorption following topical application can be rapid (e.g. from the larynx, bronchi or urethra). Systemic allergy is uncommon. PRILOCAINE Prilocaine is similar to lidocaine, but its clearance is more rapid, so it is less toxic. It is most useful when a large total amount of local anaesthetic is needed or a high plasma concentration is likely (e.g. injection into vascular areas, such as the perineum), or for use in intravenous regional anaesthesia.
EMLA is a ‘eutectic mixture of local anaesthetic’ and is a
combination of prilocaine and lidocaine in the form of a cream. If applied topically for 30–60 minutes and covered with an occlusive dressing, it provides reliable anaesthesia for venipuncture (important, especially for children). Excessive doses can lead to systemic toxicity, dependent on plasma concentration.
Prilocaine is metabolized by amidases in the
liver, kidney and lungs. The rapid production of oxidation products may rarely give rise to methaemoglobinaemia. FIN